Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeneDetect is a biotechnology company specializing in the development and manufacture of high-quality molecular biology reagents, with a primary focus on in situ hybridization (ISH) and gene expression analysis. The company provides an extensive catalog of validated oligonucleotide probes, including GreenStar fluorescent probes and biotin/digoxigenin-labeled options, catering to researchers in neuroscience, oncology, and developmental biology. Beyond catalog products, GeneDetect offers custom probe design services and specialized tissue-based assays to facilitate the localization of gene expression at the cellular level. Their products are widely used in academic and pharmaceutical research to validate drug targets and study disease pathology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GeneDetect.